Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First NDA filing for PhotoCure in U.S.

Oct. 1, 2001

Selective cdk2 inhibitor induces apoptosis, inhibits proliferation in human tumor cells

Oct. 1, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

Development candidate selected by GSK from Cytokinetics' second-generation antimitotics

Sep. 27, 2001

Phase II trial assessing Angiozyme in combination with chemotherapy initiated

Sep. 27, 2001

Enrollment completed for phase IIa trial of repifermin for mucositis

Sep. 27, 2001

First trial of thioredoxin inhibitor initiated in cancer patients

Sep. 27, 2001

Pharmacological interaction of irofulven and docetaxel under study

Sep. 27, 2001

Inhibitors of cyclin-dependent kinase identified at BMS

Sep. 26, 2001

Canadian authorities approve Gleevec following priority review

Sep. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...